Management of Relapsed/Refractory All with Inotuzumab During COVID-19. A Case Report

Management of patients with concomitant acute lymphoblastic leukemia (ALL) and COVID-19 infection is challenging. We describe the clinical history of a 40-year-old male with relapsed B-common ALL who developed Sars-CoV2 prior to treatment initiation with inotuzumab. Since the patient was asymptomati...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Palma, Martina, Gentilini, Elio, Masucci, Chiara, Micozzi, Alessandra, Turriziani, Ombretta, Mulè, Antonino, Foà, Robin, Martelli, Maurizio, D’Ettorre, Gabriella, Capria, Saveria, Chiaretti, Sabina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9084234/
https://www.ncbi.nlm.nih.gov/pubmed/35615334
http://dx.doi.org/10.4084/MJHID.2022.043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9084234/
https://www.ncbi.nlm.nih.gov/pubmed/35615334
http://dx.doi.org/10.4084/MJHID.2022.043

Ejemplares similares